DYN FY 2012 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-99.8% YoY

Gross Profit

-$265M-8833.3% margin

Operating Income

$714M23800.0% margin

Net Income

$87M2900.0% margin

EPS (Diluted)

$0.87

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$44M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$4.5B

Total Liabilities

$2.0B

Stockholders' Equity

$2.5B

Cash & Equivalents

$348M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$1.6B	-99.8%
Gross Profit	-$265M	$622M	-142.6%
Operating Income	$714M	-$236M	+402.5%
Net Income	$87M	-$1.6B	+105.3%